Detalhe da pesquisa
1.
Incorporating neoadjuvant chemotherapy into locally advanced colon cancer treatment pathways: Real-life experience of implementing FOxTROT.
Colorectal Dis
; 25(3): 352-356, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36511125
2.
Personalizing neoadjuvant chemotherapy for locally advanced colon cancer: protocols for the international phase III FOxTROT2 and FOxTROT3 randomized controlled trials.
Colorectal Dis
; 25(3): 357-366, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710525
3.
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer.
Clin Trials
; 19(2): 146-157, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083924
4.
Addressing the variation in adjuvant chemotherapy treatment for colorectal cancer: Can a regional intervention promote national change?
Int J Cancer
; 148(4): 845-856, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818319
5.
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.
Br J Cancer
; 125(8): 1080-1088, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253874
6.
Neoadjuvant chemotherapy for locally advanced colonic cancer is the standard of care.
Br J Surg
; 110(12): 1679-1680, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740517
7.
Can D-Dimer Measurement Reduce the Frequency of Radiological Assessment in Patients Receiving Palliative Imatinib for Gastrointestinal Stromal Tumor (GIST)?
Cancer Invest
; 33(8): 347-53, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26135352
8.
The impact of mismatch repair status and systemic inflammatory markers on radiological staging in colon cancer.
Br J Radiol
; 96(1150): 20230098, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493144
9.
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial.
J Clin Oncol
; 41(8): 1541-1552, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657089
10.
Ovarian cancer: advances in first-line treatment strategies with a particular focus on anti-angiogenic agents.
Curr Oncol Rep
; 14(6): 509-18, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22948277
11.
A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial.
BMJ Open
; 12(4): e049119, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487526
12.
EGFR Amplification in Metastatic Colorectal Cancer.
J Natl Cancer Inst
; 113(11): 1561-1569, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825902
13.
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring.
J Clin Oncol
; 39(33): 3705-3715, 2021 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538072
14.
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial.
J Clin Oncol
; 39(33): 3693-3704, 2021 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516759
15.
Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer.
Clin Cancer Res
; 27(12): 3422-3431, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33888518
16.
Colorectal cancer peritoneal metastases: Biology, treatment and next steps.
Eur J Surg Oncol
; 46(4 Pt A): 675-683, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806517
17.
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer.
Drugs
; 79(13): 1375-1394, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31347092
18.
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer.
JAMA Oncol
; 4(4): 564-568, 2018 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29075780
19.
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial.
Lancet Gastroenterol Hepatol
; 3(3): 162-171, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29254887
20.
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer.
JAMA Oncol
; 2(5): 633-642, 2016 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26867820